메뉴 건너뛰기




Volumn 145, Issue 5, 2013, Pages

Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: A nationwide retrospective cohort study

Author keywords

Cancer Risk; IBD; Inflammatory Bowel Disease; Medication

Indexed keywords

AZATHIOPRINE; BALSALAZIDE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; OLSALAZINE; SALAZOSULFAPYRIDINE;

EID: 84886267819     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.07.035     Document Type: Article
Times cited : (186)

References (53)
  • 1
    • 36549001139 scopus 로고    scopus 로고
    • The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
    • M.D. Kappelman, S.L. Rifas-Shiman, and K. Kleinman The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States Clin Gastroenterol Hepatol 5 2007 1424 1429
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 1424-1429
    • Kappelman, M.D.1    Rifas-Shiman, S.L.2    Kleinman, K.3
  • 2
    • 79953777773 scopus 로고    scopus 로고
    • Glucocorticosteroid therapy in inflammatory bowel disease: Systematic review and meta-analysis
    • quiz 600
    • A.C. Ford, C.N. Bernstein, and K.J. Khan Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis Am J Gastroenterol 106 2011 590 599 quiz 600
    • (2011) Am J Gastroenterol , vol.106 , pp. 590-599
    • Ford, A.C.1    Bernstein, C.N.2    Khan, K.J.3
  • 3
    • 0028082371 scopus 로고
    • Glucocorticoids and the risk for initiation of hypoglycemic therapy
    • J.H. Gurwitz, R.L. Bohn, and R.J. Glynn Glucocorticoids and the risk for initiation of hypoglycemic therapy Arch Intern Med 154 1994 97 101
    • (1994) Arch Intern Med , vol.154 , pp. 97-101
    • Gurwitz, J.H.1    Bohn, R.L.2    Glynn, R.J.3
  • 4
    • 0024762524 scopus 로고
    • Risk of infectious complications in patients taking glucocorticosteroids
    • A.E. Stuck, C.E. Minder, and F.J. Frey Risk of infectious complications in patients taking glucocorticosteroids Rev Infect Dis 11 1989 954 963
    • (1989) Rev Infect Dis , vol.11 , pp. 954-963
    • Stuck, A.E.1    Minder, C.E.2    Frey, F.J.3
  • 6
    • 0026609223 scopus 로고
    • Nontraumatic necrosis of bone (osteonecrosis)
    • H.J. Mankin Nontraumatic necrosis of bone (osteonecrosis) N Engl J Med 326 1992 1473 1479
    • (1992) N Engl J Med , vol.326 , pp. 1473-1479
    • Mankin, H.J.1
  • 7
    • 1342304173 scopus 로고    scopus 로고
    • Lymphomas after solid organ transplantation: A collaborative transplant study report
    • G. Opelz, and B. Döhler Lymphomas after solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2004 222 230
    • (2004) Am J Transplant , vol.4 , pp. 222-230
    • Opelz, G.1    Döhler, B.2
  • 8
    • 46749126662 scopus 로고    scopus 로고
    • Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients
    • F. Pietersma, E. Piriou, and D. van Baarle Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients Leuk Lymphoma 49 2008 1028 1041
    • (2008) Leuk Lymphoma , vol.49 , pp. 1028-1041
    • Pietersma, F.1    Piriou, E.2    Van Baarle, D.3
  • 9
    • 0036143781 scopus 로고    scopus 로고
    • Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
    • G.A. Dayharsh, E.V. Loftus, and W.J. Sandborn Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine Gastroenterology 122 2002 72 77
    • (2002) Gastroenterology , vol.122 , pp. 72-77
    • Dayharsh, G.A.1    Loftus, E.V.2    Sandborn, W.J.3
  • 10
    • 0028147042 scopus 로고
    • Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease
    • L. Larvol, J.C. Soule, and A. Le Tourneau Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease N Engl J Med 331 1994 883 884
    • (1994) N Engl J Med , vol.331 , pp. 883-884
    • Larvol, L.1    Soule, J.C.2    Le Tourneau, A.3
  • 11
    • 0027131566 scopus 로고
    • Intestinal cancer risk and mortality in patients with Crohn's disease
    • P. Munkholm, E. Langholz, and M. Davidsen Intestinal cancer risk and mortality in patients with Crohn's disease Gastroenterology 105 1993 1716 1723
    • (1993) Gastroenterology , vol.105 , pp. 1716-1723
    • Munkholm, P.1    Langholz, E.2    Davidsen, M.3
  • 12
    • 0026482857 scopus 로고
    • Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction
    • A.J. Wakefield, J.D. Fox, and A.M. Sawyerr Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction J Med Virol 38 1992 183 190
    • (1992) J Med Virol , vol.38 , pp. 183-190
    • Wakefield, A.J.1    Fox, J.D.2    Sawyerr, A.M.3
  • 13
    • 0035728599 scopus 로고    scopus 로고
    • Colorectal neoplasia in ulcerative colitis-recent advances
    • N.A. Wong, and D.J. Harrison Colorectal neoplasia in ulcerative colitis-recent advances Histopathology 39 2001 221 234
    • (2001) Histopathology , vol.39 , pp. 221-234
    • Wong, N.A.1    Harrison, D.J.2
  • 14
    • 0032851120 scopus 로고    scopus 로고
    • Human RNase H-mediated RNA cleavage from DNA-RNA duplexes is inhibited by 6-deoxythioguanosine incorporation into DNA
    • N.F. Krynetskaia, E.Y. Krynetski, and W.E. Evans Human RNase H-mediated RNA cleavage from DNA-RNA duplexes is inhibited by 6-deoxythioguanosine incorporation into DNA Mol Pharmacol 56 1999 841 848
    • (1999) Mol Pharmacol , vol.56 , pp. 841-848
    • Krynetskaia, N.F.1    Krynetski, E.Y.2    Evans, W.E.3
  • 15
    • 0033747215 scopus 로고    scopus 로고
    • Thioguanine substitution alters DNA cleavage mediated by topoisomerase II
    • N.F. Krynetskaia, X. Cai, and J.L. Nitiss Thioguanine substitution alters DNA cleavage mediated by topoisomerase II FASEB J 14 2000 2339 2344
    • (2000) FASEB J , vol.14 , pp. 2339-2344
    • Krynetskaia, N.F.1    Cai, X.2    Nitiss, J.L.3
  • 16
    • 0027074626 scopus 로고
    • Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase, and endonuclease reactions
    • Y.H. Ling, J.Y. Chan, and K.L. Beattie Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase, and endonuclease reactions Mol Pharmacol 42 1992 802 807
    • (1992) Mol Pharmacol , vol.42 , pp. 802-807
    • Ling, Y.H.1    Chan, J.Y.2    Beattie, K.L.3
  • 17
    • 0037428478 scopus 로고    scopus 로고
    • Structure and dynamics of thioguanine-modified duplex DNA
    • L. Somerville, E.Y. Krynetski, and N.F. Krynetskaia Structure and dynamics of thioguanine-modified duplex DNA J Biol Chem 278 2003 1005 1011
    • (2003) J Biol Chem , vol.278 , pp. 1005-1011
    • Somerville, L.1    Krynetski, E.Y.2    Krynetskaia, N.F.3
  • 18
    • 0028363515 scopus 로고
    • Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
    • W.R. Connell, M.A. Kamm, and M. Dickson Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease Lancet 343 1994 1249 1252
    • (1994) Lancet , vol.343 , pp. 1249-1252
    • Connell, W.R.1    Kamm, M.A.2    Dickson, M.3
  • 19
    • 0043011380 scopus 로고    scopus 로고
    • Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis
    • J.I. Warman, B.I. Korelitz, and M.R. Fleisher Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis J Clin Gastroenterol 37 2003 220 225
    • (2003) J Clin Gastroenterol , vol.37 , pp. 220-225
    • Warman, J.I.1    Korelitz, B.I.2    Fleisher, M.R.3
  • 20
    • 0033795223 scopus 로고    scopus 로고
    • Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
    • R.J. Farrell, Y. Ang, and P. Kileen Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low Gut 47 2000 514 519
    • (2000) Gut , vol.47 , pp. 514-519
    • Farrell, R.J.1    Ang, Y.2    Kileen, P.3
  • 21
    • 70449100743 scopus 로고    scopus 로고
    • Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study
    • L. Beaugerie, N. Brousse, and A.M. Bouvier Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study Lancet 374 2009 1617 1625
    • (2009) Lancet , vol.374 , pp. 1617-1625
    • Beaugerie, L.1    Brousse, N.2    Bouvier, A.M.3
  • 22
    • 0034764110 scopus 로고    scopus 로고
    • Inflammatory bowel disease is not associated with an increased risk of lymphoma
    • J.D. Lewis, W.B. Bilker, and C. Brensinger Inflammatory bowel disease is not associated with an increased risk of lymphoma Gastroenterology 121 2001 1080 1087
    • (2001) Gastroenterology , vol.121 , pp. 1080-1087
    • Lewis, J.D.1    Bilker, W.B.2    Brensinger, C.3
  • 23
    • 82955195113 scopus 로고    scopus 로고
    • Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease
    • L.J. Herrinton, L. Liu, and X. Weng Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease Am J Gastroenterol 106 2011 2146 2153
    • (2011) Am J Gastroenterol , vol.106 , pp. 2146-2153
    • Herrinton, L.J.1    Liu, L.2    Weng, X.3
  • 24
    • 84875626330 scopus 로고    scopus 로고
    • The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe
    • P.L. Lakatos, B.D. Lovasz, and G. David The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe J Crohns Colitis 7 2013 385 391
    • (2013) J Crohns Colitis , vol.7 , pp. 385-391
    • Lakatos, P.L.1    Lovasz, B.D.2    David, G.3
  • 25
    • 22644446331 scopus 로고    scopus 로고
    • Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    • A. Kandiel, A.G. Fraser, and B.I. Korelitz Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine Gut 54 2005 1121 1125
    • (2005) Gut , vol.54 , pp. 1121-1125
    • Kandiel, A.1    Fraser, A.G.2    Korelitz, B.I.3
  • 26
    • 33846448180 scopus 로고    scopus 로고
    • Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease
    • Y. Masunaga, K. Ohno, and R. Ogawa Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease Ann Pharmacother 41 2007 21 28
    • (2007) Ann Pharmacother , vol.41 , pp. 21-28
    • Masunaga, Y.1    Ohno, K.2    Ogawa, R.3
  • 27
    • 84878479769 scopus 로고    scopus 로고
    • The National Center for Veterans Analysis and Statistics (NCVAS) Washington, DC
    • The National Center for Veterans Analysis and Statistics (NCVAS). Trends in the utilization of VA programs and services. 2012. Washington, DC. Available at: http://www.va.gov/vetdata/docs/quickfacts/Utilization-slideshow.pdf.
    • (2012) Trends in the Utilization of VA Programs and Services
  • 29
    • 77956187753 scopus 로고    scopus 로고
    • Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans
    • S. Thirumurthi, R. Chowdhury, and P. Richardson Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans Dig Dis Sci 55 2010 2592 2598
    • (2010) Dig Dis Sci , vol.55 , pp. 2592-2598
    • Thirumurthi, S.1    Chowdhury, R.2    Richardson, P.3
  • 30
    • 55949103220 scopus 로고    scopus 로고
    • Autoimmune and inflammatory disorders and risk of malignant lymphomas - An update
    • K.E. Smedby, J. Askling, and X. Mariette Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update J Intern Med 264 2008 514 527
    • (2008) J Intern Med , vol.264 , pp. 514-527
    • Smedby, K.E.1    Askling, J.2    Mariette, X.3
  • 31
    • 40549087905 scopus 로고    scopus 로고
    • Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma
    • L. Mellemkjaer, R.M. Pfeiffer, and E.A. Engels Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma Arthritis Rheum 58 2008 657 666
    • (2008) Arthritis Rheum , vol.58 , pp. 657-666
    • Mellemkjaer, L.1    Pfeiffer, R.M.2    Engels, E.A.3
  • 32
    • 27844511909 scopus 로고    scopus 로고
    • The risk of lymphoma development in autoimmune diseases: A meta-analysis
    • E. Zintzaras, M. Voulgarelis, and H.M. Moutsopoulos The risk of lymphoma development in autoimmune diseases: a meta-analysis Arch Intern Med 165 2005 2337 2344
    • (2005) Arch Intern Med , vol.165 , pp. 2337-2344
    • Zintzaras, E.1    Voulgarelis, M.2    Moutsopoulos, H.M.3
  • 33
    • 0032543858 scopus 로고    scopus 로고
    • Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study
    • E. Baecklund, A. Ekbom, and P. Sparén Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study BMJ 317 1998 180 181
    • (1998) BMJ , vol.317 , pp. 180-181
    • Baecklund, E.1    Ekbom, A.2    Sparén, P.3
  • 34
    • 33644892763 scopus 로고    scopus 로고
    • Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
    • E. Baecklund, A. Iliadou, and J. Askling Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis Arthritis Rheum 54 2006 692 701
    • (2006) Arthritis Rheum , vol.54 , pp. 692-701
    • Baecklund, E.1    Iliadou, A.2    Askling, J.3
  • 35
    • 17644386242 scopus 로고    scopus 로고
    • Risk of haematopoietic cancer in patients with inflammatory bowel disease
    • J. Askling, L. Brandt, and A. Lapidus Risk of haematopoietic cancer in patients with inflammatory bowel disease Gut 54 2005 617 622
    • (2005) Gut , vol.54 , pp. 617-622
    • Askling, J.1    Brandt, L.2    Lapidus, A.3
  • 37
    • 0033119199 scopus 로고    scopus 로고
    • Increased risk of cancer in ulcerative colitis: A population-based cohort study
    • P. Karlén, R. Löfberg, and O. Broström Increased risk of cancer in ulcerative colitis: a population-based cohort study Am J Gastroenterol 94 1999 1047 1052
    • (1999) Am J Gastroenterol , vol.94 , pp. 1047-1052
    • Karlén, P.1    Löfberg, R.2    Broström, O.3
  • 38
    • 0032811701 scopus 로고    scopus 로고
    • Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases
    • P. Asten, J. Barrett, and D. Symmons Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases J Rheumatol 26 1999 1705 1714
    • (1999) J Rheumatol , vol.26 , pp. 1705-1714
    • Asten, P.1    Barrett, J.2    Symmons, D.3
  • 39
    • 0024242251 scopus 로고
    • Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: A 20 year follow up study
    • A.J. Silman, J. Petrie, and B. Hazleman Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study Ann Rheum Dis 47 1988 988 992
    • (1988) Ann Rheum Dis , vol.47 , pp. 988-992
    • Silman, A.J.1    Petrie, J.2    Hazleman, B.3
  • 40
    • 70149110219 scopus 로고    scopus 로고
    • Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease
    • T. Nguyen, P.M. Vacek, and P. O'Neill Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease Cancer Res 69 2009 7004 7012
    • (2009) Cancer Res , vol.69 , pp. 7004-7012
    • Nguyen, T.1    Vacek, P.M.2    O'Neill, P.3
  • 41
    • 0022004061 scopus 로고
    • Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
    • L.J. Kinlen Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment Am J Med 78 1985 44 49
    • (1985) Am J Med , vol.78 , pp. 44-49
    • Kinlen, L.J.1
  • 42
    • 77954426838 scopus 로고    scopus 로고
    • Risk of cancer in inflammatory bowel disease treated with azathioprine: A UK population-based case-control study
    • R.G. Armstrong, J. West, and T.R. Card Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study Am J Gastroenterol 105 2010 1604 1609
    • (2010) Am J Gastroenterol , vol.105 , pp. 1604-1609
    • Armstrong, R.G.1    West, J.2    Card, T.R.3
  • 43
    • 0034075584 scopus 로고    scopus 로고
    • Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
    • J.D. Lewis, J.S. Schwartz, and G.R. Lichtenstein Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma Gastroenterology 118 2000 1018 1024
    • (2000) Gastroenterology , vol.118 , pp. 1018-1024
    • Lewis, J.D.1    Schwartz, J.S.2    Lichtenstein, G.R.3
  • 44
    • 51949104939 scopus 로고    scopus 로고
    • Incidence and mortality from non-Hodgkin lymphoma in Europe: The end of an epidemic?
    • C. Bosetti, F. Levi, and J. Ferlay Incidence and mortality from non-Hodgkin lymphoma in Europe: the end of an epidemic? Int J Cancer 123 2008 1917 1923
    • (2008) Int J Cancer , vol.123 , pp. 1917-1923
    • Bosetti, C.1    Levi, F.2    Ferlay, J.3
  • 45
    • 77953801701 scopus 로고    scopus 로고
    • Review article: Malignancy on thiopurine treatment with special reference to inflammatory bowel disease
    • M.A. Smith, P.M. Irving, and A.M. Marinaki Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease Aliment Pharmacol Ther 32 2010 119 130
    • (2010) Aliment Pharmacol Ther , vol.32 , pp. 119-130
    • Smith, M.A.1    Irving, P.M.2    Marinaki, A.M.3
  • 46
    • 0035166741 scopus 로고    scopus 로고
    • Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
    • A. Bitton, M.A. Peppercorn, and D.A. Antonioli Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis Gastroenterology 120 2001 13 20
    • (2001) Gastroenterology , vol.120 , pp. 13-20
    • Bitton, A.1    Peppercorn, M.A.2    Antonioli, D.A.3
  • 47
    • 84886797351 scopus 로고    scopus 로고
    • Lymphoproliferative disorders in patients receiving thiopurines for ulcerative colitis: A nationwide 10-year retrospective cohort from the Veterans Affairs healthcare system
    • A. Abbas, Y. Koleva, and N. Khan Lymphoproliferative disorders in patients receiving thiopurines for ulcerative colitis: a nationwide 10-year retrospective cohort from the Veterans Affairs healthcare system Am J Gastroenterol 107 2012 S693
    • (2012) Am J Gastroenterol , vol.107 , pp. 693
    • Abbas, A.1    Koleva, Y.2    Khan, N.3
  • 48
    • 84866428073 scopus 로고    scopus 로고
    • Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: Nationwide 10-year retrospective cohort from the veterans affairs healthcare system
    • N. Khan, A.M. Abbas, and L.A. Bazzano Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare system Aliment Pharmacol Ther 36 2012 755 764
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 755-764
    • Khan, N.1    Abbas, A.M.2    Bazzano, L.A.3
  • 49
    • 84861335038 scopus 로고    scopus 로고
    • Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis
    • J.K. Hou, J.R. Kramer, and P. Richardson Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis Inflamm Bowel Dis 18 2012 1011 1017
    • (2012) Inflamm Bowel Dis , vol.18 , pp. 1011-1017
    • Hou, J.K.1    Kramer, J.R.2    Richardson, P.3
  • 50
    • 67649951536 scopus 로고    scopus 로고
    • Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006
    • A. Sonnenberg, P.A. Richardson, and N.S. Abraham Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006 Dig Dis Sci 54 2009 1740 1745
    • (2009) Dig Dis Sci , vol.54 , pp. 1740-1745
    • Sonnenberg, A.1    Richardson, P.A.2    Abraham, N.S.3
  • 52
    • 64549134707 scopus 로고    scopus 로고
    • VHA pharmacy use in veterans with Medicare drug coverage
    • R.O. Morgan, L.A. Petersen, and J.C. Hasche VHA pharmacy use in veterans with Medicare drug coverage Am J Manag Care 15 2009 e1 8
    • (2009) Am J Manag Care , vol.15 , pp. 1-8
    • Morgan, R.O.1    Petersen, L.A.2    Hasche, J.C.3
  • 53
    • 33750277174 scopus 로고    scopus 로고
    • Dual use of Medicare and the Veterans Health Administration: Are there adverse health outcomes?
    • F.D. Wolinsky, T.R. Miller, and H. An Dual use of Medicare and the Veterans Health Administration: are there adverse health outcomes? BMC Health Serv Res 6 2006 131
    • (2006) BMC Health Serv Res , vol.6 , pp. 131
    • Wolinsky, F.D.1    Miller, T.R.2    An, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.